3/21
04:14 pm
derm
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
High
Report
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
3/21
04:01 pm
derm
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Medium
Report
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
3/19
10:06 am
derm
Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA [Yahoo! Finance]
Medium
Report
Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA [Yahoo! Finance]
3/18
08:30 am
derm
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
High
Report
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
3/15
08:56 am
derm
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 [Yahoo! Finance]
Low
Report
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 [Yahoo! Finance]
3/15
08:30 am
derm
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
Low
Report
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
3/13
08:54 am
derm
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference [Yahoo! Finance]
Low
Report
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference [Yahoo! Finance]
3/13
08:30 am
derm
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
Low
Report
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
3/11
08:52 am
derm
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting [Yahoo! Fina
Low
Report
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting [Yahoo! Fina
3/11
08:30 am
derm
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
Medium
Report
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
3/8
06:46 am
derm
Journey Medical Insiders Up US$187k On US$520.8k Investment [Yahoo! Finance]
Low
Report
Journey Medical Insiders Up US$187k On US$520.8k Investment [Yahoo! Finance]
2/26
01:08 pm
derm
Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards? [Yahoo! Finance]
Low
Report
Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards? [Yahoo! Finance]
2/16
08:10 am
derm
Journey Medical Co. (NASDAQ: DERM) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $8.50 price target on the stock.
Medium
Report
Journey Medical Co. (NASDAQ: DERM) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $8.50 price target on the stock.
1/23
04:24 pm
derm
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update [Yahoo! Finance]
Medium
Report
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update [Yahoo! Finance]